We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Beta-blocker use did not reduce risk for death or new MI ...
Credit: Getty Images. The approval was based on data from the phase 3 EMPEROR-Reduced trial. The Food and Drug Administration (FDA) has approved Jardiance ® (empagliflozin) to reduce the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback